Cargando…
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer
SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and the second leading cause of cancer deaths in US men. Resistance to standard medical castration and secondary taxane-based chemotherapy, the presence of cancer stem-like cells representing epithelial to mesenchymal transdiffer...
Autores principales: | Mazumder, Suman, Mitra Ghosh, Taraswi, Mukherjee, Ujjal K., Chakravarti, Sayak, Amiri, Farshad, Waliagha, Razan S., Hemmati, Farnaz, Mistriotis, Panagiotis, Ahmed, Salsabil, Elhussin, Isra, Salam, Ahmad-Bin, Dean-Colomb, Windy, Yates, Clayton, Arnold, Robert D., Mitra, Amit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738762/ https://www.ncbi.nlm.nih.gov/pubmed/36497496 http://dx.doi.org/10.3390/cancers14236009 |
Ejemplares similares
-
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers
por: Mitra Ghosh, Taraswi, et al.
Publicado: (2023) -
secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics
por: Kumar, Harish, et al.
Publicado: (2022) -
Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells
por: Kumar, Harish, et al.
Publicado: (2022) -
Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results
por: Di Francia, Raffaele, et al.
Publicado: (2017) -
Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition
por: Davis, Joshua T., et al.
Publicado: (2023)